Temozolomide in patients with high grade gliomas

Alba Ariela Brandes, Lara Maria Pasetto, Francesca Vastola, Silvio Monfardini

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The incidence of central nervous system neoplasias ranges from 3.8 to 5.1 cases per 100,000 inhabitants. First-line treatment of brain tumors consists of surgery associated with radiotherapy, and followed or not by chemotherapy. When used as an adjuvant therapy after surgery and radiotherapy, chemotherapy prolongs the time to progression and the median survival time. At relapse, chemotherapy is the common therapeutic approach. In recent years, new drugs for the treatment of brain tumors have been tested, and some of them, such as temozolomide, are very promising. Copyright (C) 2000 S. Karger AG, Basel.

Original languageEnglish
Pages (from-to)181-186
Number of pages6
JournalOncology
Volume59
Issue number3
Publication statusPublished - 2000

Fingerprint

temozolomide
Glioma
Drug Therapy
Brain Neoplasms
Radiotherapy
Therapeutics
Central Nervous System
Recurrence
Survival
Incidence
Pharmaceutical Preparations

Keywords

  • Brain tumors
  • Chemotherapy
  • Temozolomide

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Brandes, A. A., Pasetto, L. M., Vastola, F., & Monfardini, S. (2000). Temozolomide in patients with high grade gliomas. Oncology, 59(3), 181-186.

Temozolomide in patients with high grade gliomas. / Brandes, Alba Ariela; Pasetto, Lara Maria; Vastola, Francesca; Monfardini, Silvio.

In: Oncology, Vol. 59, No. 3, 2000, p. 181-186.

Research output: Contribution to journalArticle

Brandes, AA, Pasetto, LM, Vastola, F & Monfardini, S 2000, 'Temozolomide in patients with high grade gliomas', Oncology, vol. 59, no. 3, pp. 181-186.
Brandes AA, Pasetto LM, Vastola F, Monfardini S. Temozolomide in patients with high grade gliomas. Oncology. 2000;59(3):181-186.
Brandes, Alba Ariela ; Pasetto, Lara Maria ; Vastola, Francesca ; Monfardini, Silvio. / Temozolomide in patients with high grade gliomas. In: Oncology. 2000 ; Vol. 59, No. 3. pp. 181-186.
@article{ae52ddb571be4ee98f206650d90200c9,
title = "Temozolomide in patients with high grade gliomas",
abstract = "The incidence of central nervous system neoplasias ranges from 3.8 to 5.1 cases per 100,000 inhabitants. First-line treatment of brain tumors consists of surgery associated with radiotherapy, and followed or not by chemotherapy. When used as an adjuvant therapy after surgery and radiotherapy, chemotherapy prolongs the time to progression and the median survival time. At relapse, chemotherapy is the common therapeutic approach. In recent years, new drugs for the treatment of brain tumors have been tested, and some of them, such as temozolomide, are very promising. Copyright (C) 2000 S. Karger AG, Basel.",
keywords = "Brain tumors, Chemotherapy, Temozolomide",
author = "Brandes, {Alba Ariela} and Pasetto, {Lara Maria} and Francesca Vastola and Silvio Monfardini",
year = "2000",
language = "English",
volume = "59",
pages = "181--186",
journal = "Oncology",
issn = "0030-2414",
publisher = "UBM Medica Healthcare Publications",
number = "3",

}

TY - JOUR

T1 - Temozolomide in patients with high grade gliomas

AU - Brandes, Alba Ariela

AU - Pasetto, Lara Maria

AU - Vastola, Francesca

AU - Monfardini, Silvio

PY - 2000

Y1 - 2000

N2 - The incidence of central nervous system neoplasias ranges from 3.8 to 5.1 cases per 100,000 inhabitants. First-line treatment of brain tumors consists of surgery associated with radiotherapy, and followed or not by chemotherapy. When used as an adjuvant therapy after surgery and radiotherapy, chemotherapy prolongs the time to progression and the median survival time. At relapse, chemotherapy is the common therapeutic approach. In recent years, new drugs for the treatment of brain tumors have been tested, and some of them, such as temozolomide, are very promising. Copyright (C) 2000 S. Karger AG, Basel.

AB - The incidence of central nervous system neoplasias ranges from 3.8 to 5.1 cases per 100,000 inhabitants. First-line treatment of brain tumors consists of surgery associated with radiotherapy, and followed or not by chemotherapy. When used as an adjuvant therapy after surgery and radiotherapy, chemotherapy prolongs the time to progression and the median survival time. At relapse, chemotherapy is the common therapeutic approach. In recent years, new drugs for the treatment of brain tumors have been tested, and some of them, such as temozolomide, are very promising. Copyright (C) 2000 S. Karger AG, Basel.

KW - Brain tumors

KW - Chemotherapy

KW - Temozolomide

UR - http://www.scopus.com/inward/record.url?scp=0033759128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033759128&partnerID=8YFLogxK

M3 - Article

C2 - 11053983

AN - SCOPUS:0033759128

VL - 59

SP - 181

EP - 186

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 3

ER -